Wordt geladen...
Kynurenine pathway and cognitive impairments in schizophrenia: Pharmacogenetics of galantamine and memantine
The Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) project designed to facilitate the development of new drugs for the treatment of cognitive impairments in people with schizophrenia, identified three drug mechanisms of particular interest: dopaminergic, cholinerg...
Bewaard in:
| Gepubliceerd in: | Schizophr Res Cogn |
|---|---|
| Hoofdauteur: | |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Elsevier
2016
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4824953/ https://ncbi.nlm.nih.gov/pubmed/27069875 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.scog.2016.02.001 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|